Patent Licensing Agreements: Compare Options for US Businesses

For a US patent-license negotiation, prepare a scope packet, an exclusivity preference, a royalty-evidence worksheet and instructions on retained rights and termination. Start by comparing the permission each option offers—not by assuming exclusivity is preferable.

Compare NIST’s exclusive and non-exclusive options

NIST exclusive license

• Field-of-use exclusivity: NIST describes rights limited to one entity or group in a particular field.[4]
• Payments: Fees, royalties and payment frequency are negotiated using license-type and market-value factors.[4]
• Commercialization obligations: NIST requires a business-development plan and describes performance benchmarks, periodic reporting, monitoring and possible revocation.[4]

NIST non-exclusive license

• Field-of-use exclusivity: None — multiple entities may use the invention within the same field of use.[4]
• Payments: Fees, royalties and payment frequency are negotiated using license-type and market-value factors.[4]
• Commercialization obligations: Business-plan benchmarks, periodic reporting, monitoring and revocation conditions also apply.[4]

For counsel, answer: must rivals be excluded from the intended field, and can your commercialization plan support that request? Record a preferred option, commercial reason and fallback scope—such as a narrower exclusive field or non-exclusive permission. Request deal-specific payment terms rather than assuming either option has a standard price.

Build a scope packet around intended uses

A license transfers less than ownership and may be limited by time, geography or field of use. Even patent ownership does not guarantee freedom to operate despite other patents or regulatory restrictions.[1]

• Identify the rights. Gather patent and application identifiers, titles, applicable dates, ownership-chain evidence, assignments and contributor documents. USDA’s exclusive-license template identifies patents by number, title and issue date; Connecticut Innovations recommends ownership diligence.[5][8]
• Describe the business uses. Request a current claim-to-product or claim-to-service analysis for counsel to evaluate, supported by intended products, internal uses, customer groups, markets and economic assumptions.[8]
• Spell out permitted activities. USDA’s template illustrates rights to “make, have made, use, have used, sell and have sold.”[5] Ask whether the proposed language covers importing or offering for sale where relevant—both fall within US patent owners’ exclusion rights.[1]
• Separate territory from field. List intended locations separately from applications or markets: geography and field of use are distinct licensing boundaries.[1]
• Map everyone needing protection. Identify affiliates, suppliers, partners, sublicensees, customers and end users. Farella Braun + Martel’s guidance cautions that suppliers and partners may not receive the same patent-exhaustion protection as downstream purchasers.[9]

Mark each requested right required, optional or unresolved. Use this scope map to test whether the proposed exclusive or non-exclusive grant covers the business plan.

Test the royalty base against available records

Test proposed payment terms with actual invoices. As a historical example—not a universal definition—USDA’s template leaves execution, minimum and running royalty amounts for negotiation.[5]

Its net-sales definition permits these deductions from gross third-party sales:

• Customary quantity, cash, wholesaler and distributor discounts.[5]
• Credits for rejected or returned products.[5]
• Freight, transportation, insurance, duties, tariffs, sales taxes and excise taxes directly tied to sales or delivery.[5]

Sales commissions, agent commissions and collection costs are not deductible under the template. Company-produced products used internally count, except non-revenue activities such as promotions or market trials. Products count as sold when billed or invoiced; the template calls for half-yearly post-sale reports.[5]

Prepare an evidence worksheet with these suggested responsibilities—not as a statement of the template’s reporting requirements:

• Billing: Invoice date, licensed product and gross third-party sales.
• Accounting: Separate amounts for permitted deduction categories, supporting credits and reconciliation to accounting records.
• Operations: Internally used products and their revenue or non-revenue classification.

For a sample calculation, enter actual figures: gross third-party sales − permitted discounts − rejection/return credits − permitted sales/delivery charges = third-party net-sales subtotal.[5] Keep internal-use items separate for counsel to resolve their valuation.

Take counsel a reproducible calculation and a named evidence owner for each input. Separately propose record categories, retention periods, inspection notice, audit frequency, auditor qualifications, underpayment treatment and audit-cost allocation. These are negotiation requests, not documented audit requirements.

Identify retained rights and approval gates

An exclusive grant can leave others entitled to practice the invention. USDA’s template illustrates reservations to assess, not terms to assume apply to a private license.[5]

• Government uses. The template reserves an irrevocable, non-exclusive, nontransferable, royalty-free worldwide license for practice by or on behalf of the US government and, under applicable treaties or agreements, foreign governments. This includes research alone or with third parties.[5]
• Required sublicenses. USDA may require sublicenses to responsible applicants on reasonable terms for health or safety needs, or where a specific US commercial use is not being actively brought to practical application and needs public availability.[5]
• Sublicensing approval. Sublicenses require prior submission and USDA approval, which may not be unreasonably withheld. They must reference the agreement and federal retained rights, and USDA must receive copies.[5] Ask counsel which supplier, affiliate or distribution arrangements need sublicensing.
• Past conduct. Farella Braun + Martel distinguishes forward-looking permission from a release addressing past damages and recommends identifying the released actors and technology.[9] Flag earlier activity for counsel.

Give counsel maintenance and exit instructions

Under USDA’s template, stopping support for filing, prosecution or maintenance in a country leaves the company liable for costs incurred through USDA’s receipt of notice; the license in that country terminates upon receipt of written notice.[5] USDA ordinarily provides estimates, prosecution updates, opportunities to review actions and consideration of reasonable written prosecution requests.[5] Identify priority countries and spending authority before withdrawing support.

NIST ties benchmarks to the business-development plan, monitors performance and permits benchmark adjustments. Revocation circumstances include non-use, material breach, regulatory noncompliance and failure to satisfy specified federal needs.[4]

Prepare instructions on maintenance responsibility and ownership of later-developed technology.[8] Propose positions on infringement notice, enforcement control, litigation costs, settlement consent, recovery sharing, improvement grant-backs and improvement royalties. Treat these as open drafting questions, not established federal-template terms.

Ask for event-specific cure periods, post-termination treatment of products and licensed rights, and obligations that stop or survive. Connecticut Innovations recommends addressing cure events and post-termination obligations rather than assuming universal rules.[8]

What to confirm before choosing

• NIST commercial terms: NIST lists license-revocation grounds including patent non-use, material breach, regulatory noncompliance or failure to satisfy certain specified Federal needs, but does not publish standard prices, a price ranking, standard duration or universal eligibility criteria.[4]
• Royalty administration: Confirm internal-use valuation and reporting details.[5] Negotiate audit rights and reporting terms explicitly.
• Draft-specific terms: Resolve enforcement allocations, improvement rights, cure periods and surviving obligations with counsel.

Combine the scope map, option preference, royalty worksheet and rights-and-exit instructions into a counsel brief. Label each item business decision, documented source term or unanswered drafting question.

References

1. 301-Ownership/Assignability of Patents and Applications (uspto.gov)
4. Patents & Licensing | NIST (nist.gov, 2009)
5. Date of Last Revision for Website: 7/6/2020 PATENT LICENSE AGREEMENT (usda.gov)
8. 10 Tips for Preparing for IP Licensing Negotiations Connecticut Innovations (ctinnovations.com)
9. Drafting Intellectual Property Agreements: Best Practices From a Litigator’s Perspective (fbm.com, 2019)